查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627931

2024 - 2032 年电子药品市场机会、成长动力、产业趋势分析与预测

E-pharmacy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2023 年，全球电子药局市场价值将达到 862 亿美元，预计 2024 年至 2032 年复合年增长率将达到 13.3%。产品以及获取相关服务。这些数位平台提供无与伦比的便利性、隐私性和可访问性，让客户将药物直接送到家门口。

由于对便捷、可及的医疗保健解决方案的需求不断增长，该市场正在快速增长。网路连线的扩展、智慧型手机的广泛采用以及对数位医疗服务的日益偏好，大大简化了线上取得药物的过程。这种转变在管理慢性病和经常性处方方面尤其明显，这些疾病越来越多地透过电子药局处理。

市场分为两类：非处方药产品和处方药。 OTC 产品引领市场，预计未来几年将以 12.6% 的复合年增长率稳定成长。非处方药产品的主导地位可归因于消费者对自我药疗的日益偏好以及无需处方即可购买药品的便利性。随着各种易于在线获取的药物的出现，消费者越来越多地转向电子药房来满足他们的非处方药需求。慢性病盛行率的上升和人口老化推动了对非处方药产品的需求。此外，网上购物的谨慎性和送货上门的便利性也推动了这一增长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 862 亿美元
预测值 2,633 亿美元
复合年增长率 13.3%

美国在北美电子药局市场保持主导地位，预计在整个预测期内将继续保持领先地位。该国受益于强大的医疗基础设施、完善的监管框架以及数位医疗解决方案的高采用率。线上处方服务的普及以及药物送货上门的便利性极大地促进了电子药局的广泛采用。数位医疗技术的不断进步以及对改善患者护理的日益关注确保美国仍将是全球电子药房市场的关键参与者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球网路使用者数量增加
      • 增加对基于网路和线上服务的访问
      • 利润丰厚的优惠和折扣以及轻鬆获取在线处方药
      • 老年人口基数不断扩大，慢性病盛行率不断上升
    • 产业陷阱与挑战
      • 非法网路药局数量不断增加
      • 假药风险
  • 成长潜力分析
  • 监管环境
    • 我们
    • 欧洲
  • 网路药局的现况与未来
  • 电子药局商业模式
  • OTC 与 Rx 之间的分歧
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 非处方药产品
  • 处方药

第 6 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 俄罗斯
    • 比利时
    • 荷兰
    • 挪威
    • 瑞士
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 印尼
    • 纽西兰
    • 新加坡
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 埃及
    • 伊朗

第 7 章：公司简介

  • Capsule
  • Alto Pharmacy
  • Amazon
  • CVS Health
  • Express Scripts Holdings (Cigna)
  • Giant Eagle
  • MedsEngage
  • Optum Rx (UnitedHealth Group)
  • Rite Aid
  • The Kroger
  • Walgreens Boots Alliance
  • Walmart
简介目录
Product Code: 3303

The Global e-Pharmacy Market, valued at USD 86.2 billion in 2023, is projected to expand at a robust CAGR of 13.3% from 2024 to 2032. E-pharmacies are online platforms where consumers can easily purchase prescription and over-the-counter (OTC) medications and healthcare products and access related services. These digital platforms offer unparalleled convenience, privacy, and accessibility, allowing customers to have medications delivered directly to their doorsteps.

This market is growing rapidly, driven by the increasing demand for convenient, accessible healthcare solutions. The expansion of internet connectivity, widespread smartphone adoption, and a growing preference for digital health services have significantly simplified the process of accessing medications online. This shift is particularly evident in managing chronic conditions and recurring prescriptions, which are increasingly handled through e-pharmacies.

The market is divided into two categories: OTC products and prescription medicines. OTC products lead the market and are expected to grow at a steady rate of 12.6% CAGR over the coming years. The dominance of OTC products can be attributed to a growing consumer preference for self-medication and the convenience of purchasing medicines without a prescription. With a variety of easily accessible medications available online, consumers are increasingly turning to e-pharmacies for their OTC needs. The rising prevalence of chronic health conditions and the aging population drive the demand for OTC products. Additionally, the discreet nature of online purchases and the added convenience of home delivery fuel this growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$86.2 Billion
Forecast Value$263.3 Billion
CAGR13.3%

The United States maintains a dominant position in the North American e-pharmacy market and is expected to continue leading throughout the forecast period. The country benefits from a strong healthcare infrastructure, a well-established regulatory framework, and high adoption rates of digital health solutions. The popularity of online prescription services, in line with the convenience of having medications delivered to one's home, has significantly contributed to the widespread adoption of e-pharmacies. The ongoing advancements in digital health technology and the growing focus on improving patient care ensure that the U.S. will remain a key player in the global e-pharmacy market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in the number of internet users worldwide
      • 3.2.1.2 Increasing access to web-based and online services
      • 3.2.1.3 Lucrative offers and discounts along with easy availability of online prescription drugs
      • 3.2.1.4 Expanding geriatric population base coupled with growing prevalence of chronic disorders
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increasing number of illegal online pharmacies
      • 3.2.2.2 Risk of counterfeit drugs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Current and future scenario of online pharmacies
  • 3.6 E-pharmacy market script volume, by payer mix, 2021-2032
  • 3.7 E-pharmacy business models
  • 3.8 Bifurcation between OTC and Rx
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 OTC products
  • 5.3 Prescription medicine

Chapter 6 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 UK
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy
    • 6.3.6 Russia
    • 6.3.7 Belgium
    • 6.3.8 Netherlands
    • 6.3.9 Norway
    • 6.3.10 Switzerland
  • 6.4 Asia Pacific
    • 6.4.1 Japan
    • 6.4.2 China
    • 6.4.3 India
    • 6.4.4 Australia
    • 6.4.5 South Korea
    • 6.4.6 Indonesia
    • 6.4.7 New Zealand
    • 6.4.8 Singapore
    • 6.4.9 Thailand
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
    • 6.5.3 Argentina
    • 6.5.4 Colombia
    • 6.5.5 Chile
  • 6.6 Middle East and Africa
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia
    • 6.6.3 UAE
    • 6.6.4 Egypt
    • 6.6.5 Iran

Chapter 7 Company Profiles

  • 7.1 Capsule
  • 7.2 Alto Pharmacy
  • 7.3 Amazon
  • 7.4 CVS Health
  • 7.5 Express Scripts Holdings (Cigna)
  • 7.6 Giant Eagle
  • 7.7 MedsEngage
  • 7.8 Optum Rx (UnitedHealth Group)
  • 7.9 Rite Aid
  • 7.10 The Kroger
  • 7.11 Walgreens Boots Alliance
  • 7.12 Walmart